Coleen Glessner - 07 Oct 2025 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Signature
/s/ Richard S. Lindahl, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
07 Oct 2025
Net transactions value
-$306,080
Form type
4
Filing time
16 Oct 2025, 16:21:21 UTC
Previous filing
10 Jun 2025
Next filing
10 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Glessner Coleen EVP, Quality & Ethics, and CPL 300 PROFESSIONAL DRIVE, GAITHERSBURG /s/ Richard S. Lindahl, Attorney-in-fact 16 Oct 2025 0001919170

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Sale $306,080 -30,608 -17% $10.00 144,319 07 Oct 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on December 2, 2024 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act").
F2 All shares sold at an exact price of $10.00.

Remarks:

This Form 4 was filed late due to an inadvertent administrative error. The Company will report all late Form 4s in its next proxy statement.